Positron Emission Mammography and Standard Mammography in Women at High Risk of Breast Cancer
NCT ID: NCT00896649
Last Updated: 2017-05-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
193 participants
INTERVENTIONAL
2009-02-28
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This phase III trial is studying positron emission mammography to see how well it works compared with standard mammography in women undergoing screening mammogram at Boston Medical Center.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Positron Emission Mammography and Contrast-enhanced Breast MRI
NCT02770586
A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer Screening
NCT00462891
Biennial CEM in Women With a Personal History of Breast Cancer
NCT06105749
Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer
NCT03176979
Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast Cancer
NCT01716247
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To install the breast Positron Emission Mammography system and to test and ensure its compliance with all regulatory agencies including the American College of Radiology and the Food and Drug Administration.
* To measure and compare the number of call-backs for positron emission mammography (PEM) imaging and conventional mammography.
* To measure and compare patient satisfaction for both conventional mammography and positron emission mammography in terms of comfort and pain.
OUTLINE: Patients undergo a conventional two-view mammogram and positron emission mammography (PEM). Immediately following treatment, patients complete a questionnaire on their satisfaction with the standard mammogram and the positron emission mammography.
After completion of study treatment, patients are followed annually.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
positron emission mammography
questionnaire administration digital mammography positron emission mammography
questionnaire administration
Questionnaire regarding patient satisfaction with mammogram experience and with positron emission mammography experience.
digital mammography
standard screening mammogram
positron emission mammography
one-time positron emission mammography to compare recall rates with that of standard mammogram
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire administration
Questionnaire regarding patient satisfaction with mammogram experience and with positron emission mammography experience.
digital mammography
standard screening mammogram
positron emission mammography
one-time positron emission mammography to compare recall rates with that of standard mammogram
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled to undergo screening mammogram at one of the Boston Medical Center-affiliated primary care clinics and meets 1 of the following criteria:
* Dense breast tissue
* At high-risk for breast cancer
PATIENT CHARACTERISTICS:
* Has 1 of the following racial or ethnic backgrounds based on the patient's country of birth or the mother and father's country of birth:
* Hispanic
* Haitian Creole
* African American
* Caucasian
PRIOR CONCURRENT THERAPY:
* None specified
Exclusion Criteria
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Department of Defense
FED
Boston Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gustavo Mercier
BMC Attending Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gustavo Mercier, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Boston Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston University Cancer Research Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BUMC-H-27136
Identifier Type: OTHER
Identifier Source: secondary_id
W81XWH-06-1-0309
Identifier Type: OTHER
Identifier Source: secondary_id
05063002
Identifier Type: OTHER
Identifier Source: secondary_id
HRPO #A-13777.2
Identifier Type: OTHER
Identifier Source: secondary_id
CDR0000640404
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.